Nosocomial infections with methicillin and tobramycin resistant Staphylococcus aureus--implication of physiotherapy in hospital-wide dissemination.
From January 1979 to July 1980, methicillin and tobramycin resistant Staphylococcus aureus was isolated from 45 patients at a Veteran's Administration hospital. Of these 45, 36 (80%) had clinical infections involving non-surgical wounds (16), urinary tract (10), blood (8), surgical wounds (7), and sputum (5). The epidemic strain had a single phage type (47/54/75/77/83A), a single, 16.4 Md plasmid, and produced an aminoglycoside inactivating enzyme (AAD[4']). Compared to a control group of patients with nosocomial antibiotic susceptible S. aureus infections, patients with the epidemic strain had more hospital days before a positive culture (p = .004), more severe underlying disease (p = .006), received antibiotics more often (p = .0018), and underwent physiotherapy more often (p = .00007). Although selected environmental and personnel cultures were negative for the epidemic strain, epidemiologic investigation suggested that hospital-wide dissemination of S. aureus may have occurred through patient contacts in the physiotherapy department with subsequent clusters of cases occurring on several wards.
D000328:Adult; D000617:Aminoglycosides / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D003710:Demography; D004196:Disease Outbreaks / Q000453:epidemiology; D004812:Epidemiologic Methods; D005845:Georgia; D006801:Humans; D006875:Hydrotherapy / Q000295:instrumentation; D008297:Male; D008712:Methicillin / Q000627:therapeutic use*; D008875:Middle Aged; D010403:Penicillin Resistance; D010814:Physical Therapy Department, Hospital; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*; D014031:Tobramycin / Q000627:therapeutic use*
D000617:Aminoglycosides; D008712:Methicillin; D014031:Tobramycin